The PDK1-FoxO1 signaling in adipocytes controls systemic insulin sensitivity through the 5-lipoxygenase-leukotriene B


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
26 05 2020
Historique:
pubmed: 13 5 2020
medline: 19 8 2020
entrez: 13 5 2020
Statut: ppublish

Résumé

Although adipocytes are major targets of insulin, the influence of impaired insulin action in adipocytes on metabolic homeostasis remains unclear. We here show that adipocyte-specific PDK1 (3'-phosphoinositide-dependent kinase 1)-deficient (A-PDK1KO) mice manifest impaired metabolic actions of insulin in adipose tissue and reduction of adipose tissue mass. A-PDK1KO mice developed insulin resistance, glucose intolerance, and hepatic steatosis, and this phenotype was suppressed by additional ablation of FoxO1 specifically in adipocytes (A-PDK1/FoxO1KO mice) without an effect on adipose tissue mass. Neither circulating levels of adiponectin and leptin nor inflammatory markers in adipose tissue differed between A-PDK1KO and A-PDK1/FoxO1KO mice. Lipidomics and microarray analyses revealed that leukotriene B

Identifiants

pubmed: 32393635
pii: 1921015117
doi: 10.1073/pnas.1921015117
pmc: PMC7261087
doi:

Substances chimiques

Forkhead Box Protein O1 0
Foxo1 protein, mouse 0
Leukotriene B4 1HGW4DR56D
Arachidonate 5-Lipoxygenase EC 1.13.11.34
3-Phosphoinositide-Dependent Protein Kinases EC 2.7.11.1
Pdpk1 protein, mouse EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11674-11684

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK063608
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK058282
Pays : United States

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Nature. 2006 Dec 14;444(7121):860-7
pubmed: 17167474
J Clin Invest. 2001 Nov;108(9):1359-67
pubmed: 11696581
Am J Physiol Cell Physiol. 2014 Jul 1;307(1):C39-54
pubmed: 24696140
J Endocrinol. 2010 Dec;207(3):245-55
pubmed: 20870709
Dev Cell. 2002 Jul;3(1):25-38
pubmed: 12110165
Nat Med. 2015 Mar;21(3):239-247
pubmed: 25706874
Cell Metab. 2011 Mar 2;13(3):249-59
pubmed: 21356515
Mol Cell Biol. 1999 Sep;19(9):6286-96
pubmed: 10454575
Nature. 1997 Jun 5;387(6633):620-4
pubmed: 9177352
Mol Cell Endocrinol. 2006 Jun 27;252(1-2):201-6
pubmed: 16647809
Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):517-21
pubmed: 7831322
Best Pract Res Clin Endocrinol Metab. 2005 Dec;19(4):483-99
pubmed: 16311213
Cell Metab. 2006 Apr;3(4):267-75
pubmed: 16581004
Cell. 2007 Jan 26;128(2):309-23
pubmed: 17254969
Diabetes. 2016 Aug;65(8):2187-200
pubmed: 27207510
Prog Lipid Res. 2011 Jan;50(1):35-51
pubmed: 20655950
Nat Rev Mol Cell Biol. 2010 Jan;11(1):9-22
pubmed: 20027184
Cell. 2001 Feb 23;104(4):531-43
pubmed: 11239410
J Immunol. 2011 Aug 15;187(4):1942-9
pubmed: 21742977
Cell. 2004 May 14;117(4):421-6
pubmed: 15137936
Diabetologia. 2003 Dec;46(12):1594-603
pubmed: 14605806
J Clin Invest. 2015 Feb;125(2):478-86
pubmed: 25642708
Diabetologia. 2014 Apr;57(4):819-31
pubmed: 24374551
Endocr J. 2015;62(9):787-96
pubmed: 26096452
Diabetes. 2002 Jun;51(6):1672-80
pubmed: 12031952
J Immunol. 2005 Oct 1;175(7):4217-25
pubmed: 16177061
Diabetes. 2012 Sep;61(9):2311-9
pubmed: 22688342
J Clin Invest. 2017 Mar 1;127(3):1019-1030
pubmed: 28192375
J Clin Invest. 2006 Jul;116(7):1784-92
pubmed: 16823476
Cell Metab. 2015 Oct 6;22(4):546-59
pubmed: 26445512
J Biol Chem. 2002 May 10;277(19):16632-8
pubmed: 11877406
Diabetes. 2016 Aug;65(8):2201-13
pubmed: 27207537
J Biol Chem. 2007 Jan 19;282(3):2038-46
pubmed: 17082193
Mol Cell Biol. 2012 May;32(10):2010-9
pubmed: 22431523
Acta Physiol Scand. 2005 Jan;183(1):13-30
pubmed: 15654917
Nat Med. 2001 Aug;7(8):941-6
pubmed: 11479627
Nature. 1999 Sep 2;401(6748):73-6
pubmed: 10485707
Nat Med. 2008 Feb;14(2):188-93
pubmed: 18204460
Biochem Biophys Res Commun. 2018 Oct 20;505(1):29-35
pubmed: 30236987
Trends Biochem Sci. 2007 Jul;32(7):332-41
pubmed: 17576065

Auteurs

Tetsuya Hosooka (T)

Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan.

Yusei Hosokawa (Y)

Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan.

Kaku Matsugi (K)

Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan.

Masakazu Shinohara (M)

Division of Epidemiology, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan.
The Integrated Center for Mass Spectrometry, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan.

Yoko Senga (Y)

Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan.

Yoshikazu Tamori (Y)

Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan.
Department of Internal Medicine, Chibune General Hospital, 555-0001 Osaka, Japan.

Chikako Aoki (C)

Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan.

Sho Matsui (S)

Metabolic Signal Research Center, Institute for Molecular and Cellular Regulation, Gunma University, 371-8512 Maebashi, Japan.

Tsutomu Sasaki (T)

Metabolic Signal Research Center, Institute for Molecular and Cellular Regulation, Gunma University, 371-8512 Maebashi, Japan.

Tadahiro Kitamura (T)

Metabolic Signal Research Center, Institute for Molecular and Cellular Regulation, Gunma University, 371-8512 Maebashi, Japan.

Masashi Kuroda (M)

Department of Nutrition and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, 770-8503 Tokushima, Japan.

Hiroshi Sakaue (H)

Department of Nutrition and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, 770-8503 Tokushima, Japan.

Kazuhiro Nomura (K)

Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan.

Kei Yoshino (K)

Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan.

Yuko Nabatame (Y)

Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan.

Yoshito Itoh (Y)

Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, 602-8566 Kyoto, Japan.

Kanji Yamaguchi (K)

Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, 602-8566 Kyoto, Japan.

Yoshitake Hayashi (Y)

Division of Molecular Medicine and Medical Genetics, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan.

Jun Nakae (J)

Department of Internal Medicine, Keio University School of Medicine, 160-8582 Tokyo, Japan.

Domenico Accili (D)

Department of Medicine and Naomi Berrie Diabetes Center, Columbia University, NY 10032.

Takehiko Yokomizo (T)

Department of Biochemistry, Juntendo University School of Medicine, 113-8421 Tokyo, Japan.

Susumu Seino (S)

Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan.

Masato Kasuga (M)

The Institute for Adult Diseases, Asahi Life Foundation, 103-0002 Tokyo, Japan.

Wataru Ogawa (W)

Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan; ogawa@med.kobe-u.ac.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH